GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cowealth Medical China Co Ltd (SHSE:603122) » Definitions » EV-to-EBIT

Cowealth Medical China Co (SHSE:603122) EV-to-EBIT : 35.91 (As of May. 19, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cowealth Medical China Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cowealth Medical China Co's Enterprise Value is ¥2,468 Mil. Cowealth Medical China Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥69 Mil. Therefore, Cowealth Medical China Co's EV-to-EBIT for today is 35.91.

The historical rank and industry rank for Cowealth Medical China Co's EV-to-EBIT or its related term are showing as below:

SHSE:603122' s EV-to-EBIT Range Over the Past 10 Years
Min: 18.23   Med: 32.99   Max: 55.32
Current: 35.91

During the past 7 years, the highest EV-to-EBIT of Cowealth Medical China Co was 55.32. The lowest was 18.23. And the median was 32.99.

SHSE:603122's EV-to-EBIT is ranked worse than
71.57% of 102 companies
in the Medical Diagnostics & Research industry
Industry Median: 22.375 vs SHSE:603122: 35.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cowealth Medical China Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥2,697 Mil. Cowealth Medical China Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥69 Mil. Cowealth Medical China Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.55%.


Cowealth Medical China Co EV-to-EBIT Historical Data

The historical data trend for Cowealth Medical China Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cowealth Medical China Co EV-to-EBIT Chart

Cowealth Medical China Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - - 35.59 43.04

Cowealth Medical China Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.59 28.04 29.40 43.04 39.24

Competitive Comparison of Cowealth Medical China Co's EV-to-EBIT

For the Diagnostics & Research subindustry, Cowealth Medical China Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cowealth Medical China Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cowealth Medical China Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cowealth Medical China Co's EV-to-EBIT falls into.



Cowealth Medical China Co EV-to-EBIT Calculation

Cowealth Medical China Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2467.971/68.72
=35.91

Cowealth Medical China Co's current Enterprise Value is ¥2,468 Mil.
Cowealth Medical China Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cowealth Medical China Co  (SHSE:603122) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cowealth Medical China Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=68.72/2696.85182
=2.55 %

Cowealth Medical China Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥2,697 Mil.
Cowealth Medical China Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cowealth Medical China Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cowealth Medical China Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cowealth Medical China Co (SHSE:603122) Business Description

Traded in Other Exchanges
N/A
Address
No. 1001 Qinzhou North Road, 21st Floor, Building 12, Xuhui District, Shanghai, CHN, 200131
Cowealth Medical China Co Ltd operates as a diagnostic clinical laboratory company. It has introduced radiation oncology technology into the market.

Cowealth Medical China Co (SHSE:603122) Headlines

No Headlines